These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7931272)

  • 1. Structural determinants of the Alzheimer's amyloid beta-peptide.
    Soto C; Brañes MC; Alvarez J; Inestrosa NC
    J Neurochem; 1994 Oct; 63(4):1191-8. PubMed ID: 7931272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
    Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
    J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of beta/A4 protein and amyloid precursor protein in hereditary cerebral hemorrhage with amyloidosis-Dutch type and Alzheimer's disease.
    Rozemuller AJ; Roos RA; Bots GT; Kamphorst W; Eikelenboom P; Van Nostrand WE
    Am J Pathol; 1993 May; 142(5):1449-57. PubMed ID: 7684195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and cellular biology of Alzheimer amyloid.
    Marotta CA; Majocha RE; Tate B
    J Mol Neurosci; 1992; 3(3):111-25. PubMed ID: 1627458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A beta A4 amyloid precursor protein gene and Alzheimer's disease.
    Hendriks L; Van Broeckhoven C
    Eur J Biochem; 1996 Apr; 237(1):6-15. PubMed ID: 8620894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
    Burdick D; Soreghan B; Kwon M; Kosmoski J; Knauer M; Henschen A; Yates J; Cotman C; Glabe C
    J Biol Chem; 1992 Jan; 267(1):546-54. PubMed ID: 1730616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of amyloid deposition in Alzheimer's disease.
    Beyreuther K; Bush AI; Dyrks T; Hilbich C; König G; Mönning U; Multhaup G; Prior R; Rumble B; Schubert W
    Ann N Y Acad Sci; 1991; 640():129-39. PubMed ID: 1776729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitutions of hydrophobic amino acids reduce the amyloidogenicity of Alzheimer's disease beta A4 peptides.
    Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
    J Mol Biol; 1992 Nov; 228(2):460-73. PubMed ID: 1453457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered processing characteristics of beta-amyloid-containing peptides in cytosol and in media of familial Alzheimer's disease cells.
    Matsumoto A
    Biochim Biophys Acta; 1994 Feb; 1225(3):304-10. PubMed ID: 8312378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible in vitro growth of Alzheimer disease beta-amyloid plaques by deposition of labeled amyloid peptide.
    Maggio JE; Stimson ER; Ghilardi JR; Allen CJ; Dahl CE; Whitcomb DC; Vigna SR; Vinters HV; Labenski ME; Mantyh PW
    Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5462-6. PubMed ID: 1608956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular modeling of the amyloid-beta-peptide using the homology to a fragment of triosephosphate isomerase that forms amyloid in vitro.
    Contreras CF; Canales MA; Alvarez A; De Ferrari GV; Inestrosa NC
    Protein Eng; 1999 Nov; 12(11):959-66. PubMed ID: 10585501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
    Otvos L; Szendrei GI; Lee VM; Mantsch HH
    Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure determination of extracellular fragments of amyloid proteins involved in Alzheimer's disease and Dutch-type hereditary cerebral haemorrhage with amyloidosis.
    Sorimachi K; Craik DJ
    Eur J Biochem; 1994 Jan; 219(1-2):237-51. PubMed ID: 8306991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation.
    Soto C; Castaño EM; Frangione B; Inestrosa NC
    J Biol Chem; 1995 Feb; 270(7):3063-7. PubMed ID: 7852387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The amyloid peptide precursor in Alzheimer's disease.
    Octave JN
    Acta Neurol Belg; 1995 Dec; 95(4):197-209. PubMed ID: 8553793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kunitz protease inhibitor-containing amyloid beta protein precursor immunoreactivity in Alzheimer's disease.
    Hyman BT; Tanzi RE; Marzloff K; Barbour R; Schenk D
    J Neuropathol Exp Neurol; 1992 Jan; 51(1):76-83. PubMed ID: 1740675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alzheimer disease. Role of beta A4 peptide and cerebral amyloid substance].
    Duyckaerts C; Delaère P; He Y; Seilhean D; Hauw JJ
    Presse Med; 1994 May; 23(18):848-54. PubMed ID: 7937606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.